Precision Neuroscience partners with SCI Ventures (Reeve Foundation) to advance Layer 7 for spinal cord injury
Summary
Precision Neuroscience announced a partnership with SCI Ventures — the venture investment arm of the Christopher & Dana Reeve Foundation — to advance the Layer 7 Cortical Interface for brain-computer interface applications specifically relevant to spinal cord injury patients. The Reeve Foundation's SCI patient network and clinical relationships provide Precision access to the SCI patient community that represents the primary commercial market for communication BCIs. The partnership was announced in November 2025, concurrent with Synchron's $200M Series D, demonstrating the breadth of BCI partnership activity in Q4 2025.
Why it matters
The Reeve Foundation's investment arm backing Precision Neuroscience bridges the gap between patient advocacy and commercial BCI development in a way that no pure venture fund can replicate. The Reeve Foundation's 30 years of SCI clinical network relationships, advocacy infrastructure, and patient community trust gives Precision access to the exact patient population that commercial BCI success depends on — people with spinal cord injury motivated to participate in trials and ultimately purchase approved devices.
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trial